Pharos iBio Co., Ltd. (KOSDAQ:388870)
South Korea · Delayed Price · Currency is KRW 9,870.00
-100.00 (-1.00%)
At close: Jan 23, 2026
Pharos iBio Market Cap
Pharos iBio has a market cap or net worth of 127.78 billion as of January 23, 2026. Its market cap has increased by 32.48% in one year.
Market Cap
127.78B
Enterprise Value
119.14B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
9,870.00
Market Cap Chart
Since July 27, 2023, Pharos iBio's market cap has increased from 112.78B to 127.78B, an increase of 13.29%. That is a compound annual growth rate of 5.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 127.78B | 5.11% |
| Dec 30, 2025 | 121.56B | 24.04% |
| Dec 30, 2024 | 98.00B | -48.85% |
| Dec 28, 2023 | 191.59B | 69.87% |
| Jul 27, 2023 | 112.78B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GREEN CROSS WellBeing | 164.50B |
| Kyung Dong Pharmaceutical | 152.76B |
| PHARMARESEARCH BIO | 147.16B |
| DongKoo Bio & Pharma | 140.08B |
| KOREA PHARMA | 137.86B |
| OPTUS Pharmaceutical | 133.76B |
| HYUNDAI BIOLAND | 126.00B |
| High Tech Pharm | 122.71B |